APO Research
Talk to an analyst

APO RESEARCH · REPORT

Factor IX Complex Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Factor IX Complex Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025187 pages

Choose your research edition.

Industry ResearchFactor IX Complex Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Factor IX Complex Drug Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Factor IX Complex Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Factor IX Complex Drug Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Factor IX Complex Drug Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Factor IX Complex Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Factor IX Complex Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Factor IX Complex Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Factor IX Complex Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Factor IX Complex Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Factor IX Complex Drug include Takeda, Grifols, Prothya Biosolutions, Octapharma and CSL Behring, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Factor IX Complex Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Factor IX Complex Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Factor IX Complex Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Factor IX Complex Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Factor IX Complex Drug Segment by Company

Takeda

Grifols

Prothya Biosolutions

Octapharma

CSL Behring

Factor IX Complex Drug Segment by Type

Prothromplex

Profilnine

Octaplex

Cofact

Beriplex

Other

Factor IX Complex Drug Segment by Application

Hemophilia B

Acquired Coagulation Factor Deficiency

Factor IX Complex Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Factor IX Complex Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Factor IX Complex Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Factor IX Complex Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Factor IX Complex Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Factor IX Complex Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Factor IX Complex Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Factor IX Complex Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Factor IX Complex Drug Industry Trends Table 2. Factor IX Complex Drug Industry Drivers Table 3. Factor IX Complex Drug Industry Opportunities and Challenges Table 4. Factor IX Complex Drug Industry Restraints Table 5. Global Factor IX Complex Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Factor IX Complex Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Factor IX Complex Drug Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Factor IX Complex Drug Sales Market Share by Manufacturers Table 9. Global Factor IX Complex Drug Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Factor IX Complex Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Factor IX Complex Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Factor IX Complex Drug Manufacturers, Product Type & Application Table 13. Global Factor IX Complex Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Factor IX Complex Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Prothromplex Table 17. Major Manufacturers of Profilnine Table 18. Major Manufacturers of Octaplex Table 19. Major Manufacturers of Cofact Table 20. Major Manufacturers of Beriplex Table 21. Major Manufacturers of Other Table 22. Global Factor IX Complex Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Factor IX Complex Drug Sales by Type (2021-2026) & (k units) Table 24. Global Factor IX Complex Drug Sales by Type (2027-2032) & (k units) Table 25. Global Factor IX Complex Drug Sales Market Share by Type (2021-2026) Table 26. Global Factor IX Complex Drug Sales Market Share by Type (2027-2032) Table 27. Global Factor IX Complex Drug Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 28. Global Factor IX Complex Drug Revenue by Type (2021-2026) & (k units) Table 29. Global Factor IX Complex Drug Revenue by Type (2027-2032) & (k units) Table 30. Global Factor IX Complex Drug Revenue Market Share by Type (2021-2026) Table 31. Global Factor IX Complex Drug Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Hemophilia B Table 33. Major Manufacturers of Acquired Coagulation Factor Deficiency Table 34. Global Factor IX Complex Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Factor IX Complex Drug Sales by Application (2021-2026) & (k units) Table 36. Global Factor IX Complex Drug Sales by Application (2027-2032) & (k units) Table 37. Global Factor IX Complex Drug Sales Market Share by Application (2021-2026) Table 38. Global Factor IX Complex Drug Sales Market Share by Application (2027-2032) Table 39. Global Factor IX Complex Drug Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global Factor IX Complex Drug Revenue by Application (2021-2026) & (k units) Table 41. Global Factor IX Complex Drug Revenue by Application (2027-2032) & (k units) Table 42. Global Factor IX Complex Drug Revenue Market Share by Application (2021-2026) Table 43. Global Factor IX Complex Drug Revenue Market Share by Application (2027-2032) Table 44. Global Factor IX Complex Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Factor IX Complex Drug Sales by Region (2021-2026) & (k units) Table 46. Global Factor IX Complex Drug Sales Market Share by Region (2021-2026) Table 47. Global Factor IX Complex Drug Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global Factor IX Complex Drug Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Factor IX Complex Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America Factor IX Complex Drug Sales by Country (2021-2026) & (k units) Table 51. North America Factor IX Complex Drug Sales by Country (2027-2032) & (k units) Table 52. Europe Factor IX Complex Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe Factor IX Complex Drug Sales by Country (2021-2026) & (k units) Table 54. Europe Factor IX Complex Drug Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific Factor IX Complex Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific Factor IX Complex Drug Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific Factor IX Complex Drug Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa Factor IX Complex Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa Factor IX Complex Drug Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa Factor IX Complex Drug Sales by Country (2027-2032) & (k units) Table 61. Global Factor IX Complex Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Factor IX Complex Drug Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Factor IX Complex Drug Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Factor IX Complex Drug Revenue Market Share by Region (2021-2026) Table 65. Global Factor IX Complex Drug Revenue Market Share by Region (2027-2032) Table 66. Takeda Company Information Table 67. Takeda Business Overview Table 68. Takeda Factor IX Complex Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Takeda Factor IX Complex Drug Product Portfolio Table 70. Takeda Recent Development Table 71. Grifols Company Information Table 72. Grifols Business Overview Table 73. Grifols Factor IX Complex Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Grifols Factor IX Complex Drug Product Portfolio Table 75. Grifols Recent Development Table 76. Prothya Biosolutions Company Information Table 77. Prothya Biosolutions Business Overview Table 78. Prothya Biosolutions Factor IX Complex Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Prothya Biosolutions Factor IX Complex Drug Product Portfolio Table 80. Prothya Biosolutions Recent Development Table 81. Octapharma Company Information Table 82. Octapharma Business Overview Table 83. Octapharma Factor IX Complex Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Octapharma Factor IX Complex Drug Product Portfolio Table 85. Octapharma Recent Development Table 86. CSL Behring Company Information Table 87. CSL Behring Business Overview Table 88. CSL Behring Factor IX Complex Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. CSL Behring Factor IX Complex Drug Product Portfolio Table 90. CSL Behring Recent Development Table 91. Key Raw Materials Table 92. Raw Materials Key Suppliers Table 93. Factor IX Complex Drug Distributors List Table 94. Factor IX Complex Drug Customers List Table 95. Research Programs/Design for This Report Table 96. Authors List of This Report Table 97. Secondary Sources Table 98. Primary Sources List of Figures Figure 1. Factor IX Complex Drug Product Image Figure 2. Global Factor IX Complex Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Factor IX Complex Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Factor IX Complex Drug Sales (2021-2032) & (k units) Figure 5. Global Factor IX Complex Drug Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Factor IX Complex Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Prothromplex Image Figure 9. Profilnine Image Figure 10. Octaplex Image Figure 11. Cofact Image Figure 12. Beriplex Image Figure 13. Other Image Figure 14. Global Factor IX Complex Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Factor IX Complex Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Factor IX Complex Drug Sales Market Share by Type (2021-2032) Figure 17. Global Factor IX Complex Drug Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 18. Global Factor IX Complex Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Factor IX Complex Drug Revenue Market Share by Type (2021-2032) Figure 20. Hemophilia B Image Figure 21. Acquired Coagulation Factor Deficiency Image Figure 22. Global Factor IX Complex Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Factor IX Complex Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Factor IX Complex Drug Sales Market Share by Application (2021-2032) Figure 25. Global Factor IX Complex Drug Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Factor IX Complex Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Factor IX Complex Drug Revenue Market Share by Application (2021-2032) Figure 28. North America Factor IX Complex Drug Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America Factor IX Complex Drug Sales Market Share by Country (2021-2032) Figure 30. U.S. Factor IX Complex Drug Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada Factor IX Complex Drug Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico Factor IX Complex Drug Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Factor IX Complex Drug Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Factor IX Complex Drug Sales Market Share by Country (2021-2032) Figure 35. Germany Factor IX Complex Drug Sales and Growth Rate (2021-2032) & (k units) Figure 36. France Factor IX Complex Drug Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. Factor IX Complex Drug Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy Factor IX Complex Drug Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands Factor IX Complex Drug Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Factor IX Complex Drug Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Factor IX Complex Drug Sales Market Share by Country (2021-2032) Figure 42. China Factor IX Complex Drug Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan Factor IX Complex Drug Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea Factor IX Complex Drug Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia Factor IX Complex Drug Sales and Growth Rate (2021-2032) & (k units) Figure 46. India Factor IX Complex Drug Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia Factor IX Complex Drug Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Factor IX Complex Drug Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Factor IX Complex Drug Sales Market Share by Country (2021-2032) Figure 50. Brazil Factor IX Complex Drug Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa Factor IX Complex Drug Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia Factor IX Complex Drug Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey Factor IX Complex Drug Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina Factor IX Complex Drug Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE Factor IX Complex Drug Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt Factor IX Complex Drug Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile Factor IX Complex Drug Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global Factor IX Complex Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Factor IX Complex Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Figure 61. North America Factor IX Complex Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Figure 63. Europe Factor IX Complex Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Factor IX Complex Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Factor IX Complex Drug Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Factor IX Complex Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Factor IX Complex Drug Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Factor IX Complex Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Prothromplex
  • Profilnine
  • Octaplex
  • Cofact
  • Beriplex
  • Other
Applications
  • Hemophilia B
  • Acquired Coagulation Factor Deficiency
Companies covered
  • Takeda
  • Grifols
  • Prothya Biosolutions
  • Octapharma
  • CSL Behring

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Factor IX Complex Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Factor IX Complex Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Factor IX Complex Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Factor IX Complex Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Factor IX Complex Drug Market Dynamics
  1. 2.1 Factor IX Complex Drug Industry Trends
  2. 2.2 Factor IX Complex Drug Industry Drivers
  3. 2.3 Factor IX Complex Drug Industry Opportunities and Challenges
  4. 2.4 Factor IX Complex Drug Industry Restraints
3 Factor IX Complex Drug Market by Manufacturers
  1. 3.1 Global Factor IX Complex Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Factor IX Complex Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Factor IX Complex Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Factor IX Complex Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Factor IX Complex Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Factor IX Complex Drug Manufacturers, Product Type & Application
  7. 3.7 Global Factor IX Complex Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Factor IX Complex Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Factor IX Complex Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Factor IX Complex Drug Tier 1, Tier 2, and Tier 3
4 Factor IX Complex Drug Market by Type
  1. 4.1 Factor IX Complex Drug Type Introduction
  2. 4.1.1 Prothromplex
  3. 4.1.2 Profilnine
  4. 4.1.3 Octaplex
  5. 4.1.4 Cofact
  6. 4.1.5 Beriplex
  7. 4.1.6 Other
  8. 4.2 Global Factor IX Complex Drug Sales by Type
  9. 4.2.1 Global Factor IX Complex Drug Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Factor IX Complex Drug Sales by Type (2021-2032)
  11. 4.2.3 Global Factor IX Complex Drug Sales Market Share by Type (2021-2032)
  12. 4.3 Global Factor IX Complex Drug Revenue by Type
  13. 4.3.1 Global Factor IX Complex Drug Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Factor IX Complex Drug Revenue by Type (2021-2032)
  15. 4.3.3 Global Factor IX Complex Drug Revenue Market Share by Type (2021-2032)
5 Factor IX Complex Drug Market by Application
  1. 5.1 Factor IX Complex Drug Application Introduction
  2. 5.1.1 Hemophilia B
  3. 5.1.2 Acquired Coagulation Factor Deficiency
  4. 5.2 Global Factor IX Complex Drug Sales by Application
  5. 5.2.1 Global Factor IX Complex Drug Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Factor IX Complex Drug Sales by Application (2021-2032)
  7. 5.2.3 Global Factor IX Complex Drug Sales Market Share by Application (2021-2032)
  8. 5.3 Global Factor IX Complex Drug Revenue by Application
  9. 5.3.1 Global Factor IX Complex Drug Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Factor IX Complex Drug Revenue by Application (2021-2032)
  11. 5.3.3 Global Factor IX Complex Drug Revenue Market Share by Application (2021-2032)
6 Global Factor IX Complex Drug Sales by Region
  1. 6.1 Global Factor IX Complex Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Factor IX Complex Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Factor IX Complex Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Factor IX Complex Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Factor IX Complex Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Factor IX Complex Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Factor IX Complex Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Factor IX Complex Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Factor IX Complex Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Factor IX Complex Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Factor IX Complex Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Factor IX Complex Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Factor IX Complex Drug Revenue by Region
  1. 7.1 Global Factor IX Complex Drug Revenue by Region
  2. 7.1.1 Global Factor IX Complex Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Factor IX Complex Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Factor IX Complex Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Factor IX Complex Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Factor IX Complex Drug Revenue (2021-2032)
  8. 7.2.2 North America Factor IX Complex Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Factor IX Complex Drug Revenue (2021-2032)
  11. 7.3.2 Europe Factor IX Complex Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Factor IX Complex Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Factor IX Complex Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Factor IX Complex Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Factor IX Complex Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Factor IX Complex Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Factor IX Complex Drug Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Grifols
  8. 8.2.1 Grifols Company Information
  9. 8.2.2 Grifols Business Overview
  10. 8.2.3 Grifols Factor IX Complex Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Grifols Factor IX Complex Drug Product Portfolio
  12. 8.2.5 Grifols Recent Developments
  13. 8.3 Prothya Biosolutions
  14. 8.3.1 Prothya Biosolutions Company Information
  15. 8.3.2 Prothya Biosolutions Business Overview
  16. 8.3.3 Prothya Biosolutions Factor IX Complex Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Prothya Biosolutions Factor IX Complex Drug Product Portfolio
  18. 8.3.5 Prothya Biosolutions Recent Developments
  19. 8.4 Octapharma
  20. 8.4.1 Octapharma Company Information
  21. 8.4.2 Octapharma Business Overview
  22. 8.4.3 Octapharma Factor IX Complex Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Octapharma Factor IX Complex Drug Product Portfolio
  24. 8.4.5 Octapharma Recent Developments
  25. 8.5 CSL Behring
  26. 8.5.1 CSL Behring Company Information
  27. 8.5.2 CSL Behring Business Overview
  28. 8.5.3 CSL Behring Factor IX Complex Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CSL Behring Factor IX Complex Drug Product Portfolio
  30. 8.5.5 CSL Behring Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Factor IX Complex Drug Value Chain Analysis
  2. 9.1.1 Factor IX Complex Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Factor IX Complex Drug Production Mode & Process
  6. 9.2 Factor IX Complex Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Factor IX Complex Drug Distributors
  9. 9.2.3 Factor IX Complex Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst